|Bid||26.12 x 3000|
|Ask||27.07 x 1200|
|Day's Range||25.33 - 26.16|
|52 Week Range||21.24 - 33.00|
|Beta (5Y Monthly)||0.60|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 27, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||31.78|
Subscribe to Yahoo Finance Plus to view Fair Value for ALKS
Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.
Alkermes (ALKS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Cardinal Health's (CAH) fiscal fourth-quarter results benefit from a solid performance in the Pharmaceutical segment.